PreprintAll rights reservedbioRxiv
Therapeutic Targeting of the TGFβ Pathway Augments CAR T cell Efficacy in Glioblastoma
- 1City of Hope
Related
- Resorantel: a dual-targeting therapeutic with potent efficacy against Staphylococcus aureus with low potential for drug resistance
- Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis
- Therapeutic Targeting of the LXR Pathway for Improving Myelin Integrity in Neurodegeneration
- CD47 blockade augments anti-GD2 driven phagocytosis in vitro but fails to improve in vivo efficacy in immunocompetent, chemoresistant neuroblastoma preclinical models
- Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer
BibTeX
@misc{alizadeh2026therapeutic,
title = {{Therapeutic Targeting of the TGFβ Pathway Augments CAR T cell Efficacy in Glioblastoma}},
author = {D. Alizadeh and R. A. Wong and M. S. Maker and D. J. Bellavari and J. C. Hibbard and H. M. Natri and W. Chen and M.-H. Chen and X. Wu and Y.-C. Yuan and J. R. Pecoraro and J. D. Jeppson and R. Starr and Z. Wang and N. E. Banovich and S. J. Forman and B. Badie and C. E. Brown},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.25.759450},
url = {https://www.biorxiv.org/content/10.64898/2026.10.25.759450v1},
}
RIS
TY - UNPB
TI - Therapeutic Targeting of the TGFβ Pathway Augments CAR T cell Efficacy in Glioblastoma
AU - D. Alizadeh
AU - R. A. Wong
AU - M. S. Maker
AU - D. J. Bellavari
AU - J. C. Hibbard
AU - H. M. Natri
AU - W. Chen
AU - M.-H. Chen
AU - X. Wu
AU - Y.-C. Yuan
AU - J. R. Pecoraro
AU - J. D. Jeppson
AU - R. Starr
AU - Z. Wang
AU - N. E. Banovich
AU - S. J. Forman
AU - B. Badie
AU - C. E. Brown
PY - 2026
DA - 2026/10/25
PB - bioRxiv
DO - 10.64898/2026.10.25.759450
UR - https://www.biorxiv.org/content/10.64898/2026.10.25.759450v1
SN - 2692-8205
ER -